Supplement × Prescription·a conflict·Emerging evidence

Rhodiola Rosea + Tranylcypromine

Conflict Emerging evidence

Rhodiola may have stimulant or monoaminergic effects that are poorly predictable during nonselective MAO inhibition.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Pair type
Conflict
Evidence
Emerging
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
ConflictEmerging evidence

What is happening. Rhodiola may have stimulant or monoaminergic effects that are poorly predictable during nonselective MAO inhibition.

Mechanism. Potential additive monoaminergic stimulation may increase agitation, insomnia, blood pressure, or serotonin toxicity risk.

Recommendation. Avoid rhodiola while taking tranylcypromine.

Stack Score

How it moves the number.

Effect on the composite score

If both Rhodiola Rosea and Tranylcypromine are in the same stack, this pair applies −10 to your Stack Score (per scored conflict row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1StatPearls Publishing. Tranylcypromine. NCBI Bookshelf. 2025.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.